International Psoriasis Council

Advancing Knowledge. Improving Care.

Xuejun

Zhang

,

MD, PhD

Head of the Key Laboratory of Dermatology
Anhui Medical University
Hefei
,
China
Councilor Since: October 1, 2016
IPC Councilor
Professor Xuejun Zhang is the Head of the Key Laboratory of Dermatology at the Ministry of Education, based at the First Affiliated Hospital of Anhui Medical University. He also leads the Jiangsu Innovation and Entrepreneurship Team in Dermatology at the Fourth Affiliated Hospital of Soochow University. He serves as Honorary Director of the Skin Health Research Institute at the China-Japan Friendship Hospital. In addition, he is the Leading Expert at the Dermatology Medical Center of Hainan Boao Super Hospital.

Professor Zhang is Chair of the Psoriasis Professional Committee of the Chinese Medical Association and an International Psoriasis Council (IPC) Councilor. He has held editorial leadership roles with the Journal of Investigative Dermatology (JID). He serves on the editorial boards of The British Journal of Dermatology (BJD), Journal of Dermatological Science (JDS), Journal of the European Academy of Dermatology and Venereology (JEADV), Annals of Dermatology, and Advanced Genetics. He is also Editor-in-Chief of the Textbook of Dermatovenerology (5th, 6th, 7th, 8th, and 9th editions, in Chinese).

Recognized nationally, Professor Zhang has received the Special Allowance from the State Council of China and is designated an Expert with Outstanding Contributions by the National Health Commission. He has been honored as a National Master Physician and is an Honorary Fellow of the American Academy of Dermatology. His past leadership includes serving as President of the 9th Asian Association of Dermatology and as a member of the Standing Committee of the 6th International Society of Dermatology (ISD).

Professor Zhang has published over 300 papers in high-impact journals, including The New England Journal of Medicine and Nature, with more than 13,000 citations. His research has earned awards, including the National Science and Technology Progress Award (Second Class), five provincial and municipal first-class awards, and recognition among the “Top Ten Scientific Advances in China” (2010) and the “Top Ten Scientific Achievements in Chinese Higher Education” (2012).
Last Updated:
07/10/2025

Areas of Interest

Genetics and genomics of skin disorders and other complex disease, especially psoriasis. And biologics treatment of psoriasis.

Languages Spoken

Chinese, English

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026